Last reviewed · How we verify

NCT05497921

Crossover Study to Evaluate the Efficacy of LED in Treating the Signs of Contact/Irritant Dermatitis of the Hand

Completed NA Last updated 5 October 2023
What this trial tests

NA trial testing handLITE LED device in Contact Dermatitis of Hand in 25 participants. Completed in 30 September 2023.

Timeline
7 October 2022
Primary endpoint
1 September 2023
30 September 2023

Quick facts

Lead sponsorSteven Baker
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment25
Start date7 October 2022
Primary completion1 September 2023
Estimated completion30 September 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Steven Baker

Who can join

Adults 21 to 75, any sex, with Contact Dermatitis of Hand. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is intended to be a cross over study. Subjects will treat one hand while the contralateral hand acts as a control. At the end of 6 weeks the subject will be instructed to cease treatment of the test hand and commence treatment of the control hand for 6 weeks. Efficacy will be evaluated at 6 weeks after the beginning of the treatment and 12 weeks (end of crossover).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Steven Baker trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05497921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing